歐洲心臟雜志-心血管藥物治療(EHJ-CVP)是一個(gè)國(guó)際，英語(yǔ)，同行評(píng)審的雜志，專(zhuān)門(mén)關(guān)注臨床心血管藥理學(xué)。它出版有關(guān)臨床研究的原創(chuàng)文章，使用新的和已建立的藥物和方法，以及薈萃分析和專(zhuān)題評(píng)論。該雜志旨在通過(guò)解釋和整合該領(lǐng)域的最新科學(xué)進(jìn)展，改善心血管疾病患者的藥物治療。

The European Heart Journal - Cardiovascular Pharmacotherapy (EHJ-CVP) is an international, English language, peer-reviewed journal with a specific focus on clinical cardiovascular pharmacology. It publishes original articles concerning clinical research, with new and established drugs and methods, as well as meta-analysis and topical reviews. The journal aims to improve the pharmacological treatment of patients with cardiovascular disease through interpreting and integrating new scientific developments within this area.